aluminum hydroxide (Alternagel, Amphojel, Alu-Cap, Dialume, AlH3OH)
Jump to navigation
Jump to search
Introduction
Tradename: Alternagel, Amphojel, Alu-Cap, Dialume. Al(OH)3
Indications
- symptomatic treatment of dyspepsia, peptic ulcer, GERD, hiatal hernia
- hyperphosphatemia in non-renal impaired patients
- skin irritation, including diaper rash[4]
- stress ulcer prophylaxis[4]
Contraindications
pregnancy-category :value +, ? 1st trimester
safety-in-lactation :value ?
Dosage
Tabs: 300(?), 475, 500, 600(?) mg.
Pharmacokinetics
- elimination :route kidney
- usual duration of action is 20-60 minutes if taken after meals
- effects may persist for up to 3 hours
Adverse effects
- common (> 10%)
- less common (1-10%)
- uncommon (< 1%)
- other
- decrease in GI motility
- long term use in patients with renal failure may result in aluminum toxicity
Drug interactions
- decreased absorption of many medications including:
- drug interaction(s) of iron supplements in combination with antacids
- drug interaction(s) of beta-adrenergic receptor antagonists with aluminum hydroxide
Mechanism of action
- increased pH of gastric secretions
- aluminum binds phosphate in food within the intestine
More general terms
Additional terms
Component of
- aluminum hydroxide/magnesium hydroxide/ribonuclease/angiogenin inhibitor/simethicone
- aluminum hydroxide/diphenhydramine/lidocaine/magnesium hydroxide/simethicone
- aluminum hydroxide/dimethicone/magnesium hydroxide
- aluminum hydroxide/magnesium trisilicate
- aluminum hydroxide/magnesium carbonate (Gaviscon)
- aluminum hydroxide/magnesium hydroxide/simethicone (Mylanta II, Maalox Plus)
- aluminum hydroxide/magnesium hydroxide (Maalox, Mylanta)
- aluminum hydroxide/aspirin/magnesium hydroxide (Ascriptin)
References
- ↑ The Pharmacological Basis of Therapeutics, 9th ed. Gilman et al, eds. Permagon Press/McGraw Hill, 1996
- ↑ Drug Information & Medication Formulary, Veterans Affairs, Central California Health Care System, 1st ed., Ravnan et al eds, 1998
- ↑ Kaiser Permanente Northern California Regional Drug Formulary, 1998
- ↑ 4.0 4.1 4.2 Deprecated Reference